Cargando…
Hypercalcemia of Malignancy Complicated by Osteonecrosis of the Jaw Treated With Cinacalcet
Hypercalcemia of malignancy (HCM) is a common complication seen in patients with cancer and is associated with high morbidity and mortality. Current long-term medical therapy for HCM focuses on inhibiting bone resorption with bisphosphonates or denosumab, which have the rare complication of osteonec...
Autores principales: | Vasquez, Libia, Cortes, Tiffany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580438/ https://www.ncbi.nlm.nih.gov/pubmed/37908212 http://dx.doi.org/10.1210/jcemcr/luad105 |
Ejemplares similares
-
Hypercalcemia of malignancy treated with cinacalcet
por: Asonitis, Nikolaos, et al.
Publicado: (2017) -
Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review
por: Sheehan, Michael, et al.
Publicado: (2020) -
Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift
por: O’Callaghan, Sondra, et al.
Publicado: (2020) -
Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia
por: Sethi, Bipin Kumar, et al.
Publicado: (2017) -
Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series
por: Rasmussen, Anne Qvist, et al.
Publicado: (2011)